Home »
Health
» Menstruation shuts out women from clinical trials: Editorial
Women are badly underrepresented in health research, including sport and exercise studies and even drug trials, and a big reason for the potentially dangerous disparity is their monthly period, experts say.
Related Posts:
Antimalarial drug mefloquine drove her husband 'to madness,' Sask. woman says
Clayton Matchee was charged with second-degree murder and torture in connection with the 1993 death of Somali national Shidane Abukar Arone, 16. His wife says it wasn't for an antimalarial drug, none of it would have ever ha… Read More- Dirty needles in the playground: St. John's drug dangers move into the schoolyard
In the shadow of the door where her son enters school, a St. John's mother teaches a lesson about safety and syringes.
… Read More
- Safety and oversight questions emerge over placenta capsules
Health professionals are warning new moms that consuming placenta capsules can carry health risks, and there's a lack of oversight in how they're made.
… Read More
- Toronto now has an official safe-injection site, but will drug users go?
Toronto now has two supervised injection sites — one official, one unsanctioned — where drug users can have someone watch over them, and one harm-reduction worker says the city will need both and many more if it’s going to p… Read More
- Doctors must help remedy opioid crisis in Canada, CMA meeting hears
The opioid epidemic is a complex set of overlapping crises that will take multiple strategies to solve, expert panel tells physicians.
… Read More
Articles
0 comments:
Enregistrer un commentaire